Meagan O'Neill


Washington D.C.

Services Expertise:

  • Strategy
  • Finance
  • Operations
  • Technology



  • Harvard School of Public Health Master of Science in Health Policy and Management
  • University of Maryland Bachelor of Science in Marketing
    Bachelor of Arts in Psychology

One of the reasons I went to graduate school was to gain a better understanding of opportunities to improve the healthcare delivery system. At ECG I am able to directly apply and build on this expertise as I help clients manage the dynamic period of health reform implementation. My work at ECG allows me to stay on the forefront of industry innovation as I work alongside organizations pursuing meaningful changes in the cost, quality, and efficiency of healthcare.

Blending her policy background and analytical experience, Meagan helps clients take advantage of opportunities in their markets to improve the delivery of healthcare. ECG clients value her understanding of the role of health policy in provider organizations and her detailed approach to synthesizing complex problems and vast amounts of data. Meagan draws on her experience working on strategic initiatives across the healthcare industry to help clients gain a comprehensive understanding of the issues they encounter and to offer them actionable and lasting solutions.

Before joining ECG, Meagan helped to develop and grow the global healthcare practice at the market research and polling firm Penn Schoen Berland (part of the WPP group of companies). As a Senior Project Manager, she designed and executed more than 100 research initiatives for clients to support key decisions related to strategy, tactics, positioning, messaging, and campaign effectiveness.

More recently, Meagan’s work with Partners HealthCare exposed her to the finance and strategy areas of a large, integrated health system. As a graduate intern, she supported various payor contracting and reimbursement initiatives as well as health reform strategy work. Meagan developed detailed reimbursement models to project the financial impact of proposed policy changes, and her financial analysis identified millions of revenue dollars at risk for the health system.